Tacrolimus in the treatment of myasthenia gravis in patients with an inadequate response to glucocorticoid therapy: randomized, double-blind, placebo-controlled study conducted in China

Background To determine the efficacy of low-dose, immediate-release tacrolimus in patients with myasthenia gravis (MG) with inadequate response to glucocorticoid therapy in a randomized, double-blind, placebo-controlled study. Methods Eligible patients had inadequate response to glucocorticoids (GCs...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Lei Zhou, Weibin Liu, Wei Li, Haifeng Li, Xu Zhang, Huifang Shang, Bitao Bu, Hui Deng, Qi Fang, Jimei Li, Hua Zhang, Zhi Song, Changyi Ou, Chuanzhu Yan, Tao Liu, Hongyu Zhou, Jianhong Bao, Jiahong Lu, Huawei Shi, Chongbo Zhao
Formato: Artigo
Lenguaje:Inglês
Publicado: SAGE Publishing 2017-09-01
Colección:Therapeutic Advances in Neurological Disorders
Acceso en línea:https://doi.org/10.1177/1756285617721092
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares